The differentially expressed genes were associated with upstream regulators that have previously been associated with colon cancer, such as TGFB1, MYC, and TP53. In our data, these genes were activated and influenced the downstream genes and pathways they regulate. This evidence concerns the gene MYC and colonic neoplasm.